TY - JOUR
T1 - Effects of Preexistent Hypertension on Blood Pressure and Residual Renal Function After Donor Nephrectomy
AU - Tent, Hilde
AU - Sanders, Jan-Stephan F.
AU - Rook, Mieneke
AU - Hofker, H. Sijbrand
AU - Ploeg, Rutger J.
AU - Navis, Gerjan
AU - Homan-van der Heide, Jaap J.
PY - 2012
Y1 - 2012
N2 - Background. Living kidney donor selection has become more liberal with acceptation of hypertensive donors. Here, we evaluate short-term and 1- and 5-year renal outcome of living kidney donors with preexistent hypertension. Methods. We compared outcome of hypertensive donors by gender, age, and body mass index with matched control donors. Hypertension was defined as predonation antihypertensive drug use. All donors had glomerular filtration rate (I-125-iothalamate) and effective renal plasma flow (I-131-hippuran) measured 4 months before and 2 months after donation. A subset of donors had serum creatinine measured 1 year after donation or a renal function measurement 5 years after donation. Results. Included were 47 hypertensive donors and 94 control donors (both 53% male; meanage, 57 +/- 7 years; and body mass index, 28 +/- 4 kg/m(2)). Pre- and early postdonation, systolic blood pressure, and mean arterial pressure were significantly higher in hypertensive donors. Control donors showed a rise in diastolic blood pressure after donation, and thus the predonation difference was lost postdonation. Both at 1 year (29 hypertensive donors, 58 controls) and 5 years after donation (13 hypertensive donors and 26 controls) blood pressure was similar. Renal function was similar at all time points. Discussion. In summary, hypertensive living kidney donors have similar outcome in terms of blood pressure and renal function as control donors, early and 1 and 5 years after donation
AB - Background. Living kidney donor selection has become more liberal with acceptation of hypertensive donors. Here, we evaluate short-term and 1- and 5-year renal outcome of living kidney donors with preexistent hypertension. Methods. We compared outcome of hypertensive donors by gender, age, and body mass index with matched control donors. Hypertension was defined as predonation antihypertensive drug use. All donors had glomerular filtration rate (I-125-iothalamate) and effective renal plasma flow (I-131-hippuran) measured 4 months before and 2 months after donation. A subset of donors had serum creatinine measured 1 year after donation or a renal function measurement 5 years after donation. Results. Included were 47 hypertensive donors and 94 control donors (both 53% male; meanage, 57 +/- 7 years; and body mass index, 28 +/- 4 kg/m(2)). Pre- and early postdonation, systolic blood pressure, and mean arterial pressure were significantly higher in hypertensive donors. Control donors showed a rise in diastolic blood pressure after donation, and thus the predonation difference was lost postdonation. Both at 1 year (29 hypertensive donors, 58 controls) and 5 years after donation (13 hypertensive donors and 26 controls) blood pressure was similar. Renal function was similar at all time points. Discussion. In summary, hypertensive living kidney donors have similar outcome in terms of blood pressure and renal function as control donors, early and 1 and 5 years after donation
U2 - https://doi.org/10.1097/TP.0b013e318240e9b9
DO - https://doi.org/10.1097/TP.0b013e318240e9b9
M3 - Article
C2 - 22217533
SN - 0041-1337
VL - 93
SP - 412
EP - 417
JO - Transplantation
JF - Transplantation
IS - 4
ER -